Skip to main content
. 2019 Sep 21;25:502–516.

Figure 4.

Figure 4

Kaplan–Meier cumulative metastasis-free survival proportion after enucleation. A: For patients with tumors that had a periodic acid-Schiff (PAS) density greater than the median, median survival was 15 months (95% confidence interval [CI] 7.0–23; 6.9%). Median survival was not met for tumors that had a PAS density below the median (log rank (Mantel-Cox) p=0.005). B: For patients with tumors that displayed vasculogenic mimicry (defined as the presence of networks, closed loops, or arcs with branching, or any combination), median survival was 15 months (95% CI 7.0–23). Median survival was not met for tumors without vasculogenic mimicry (log rank (Mantel-Cox) p=0.01). C: For patients with tumors that had low nuclear BAP-1 expression, median survival was 21 months (95% CI 12–30). Median survival was not met for tumors with high nuclear BAP-1 expression (log rank (Mantel-Cox) p=0.03). D: For patients with tumors of gene expression class 2, median survival was 20 months (95% CI 12–28). Median survival was not met for tumors with gene expression classes 1a or 1b (log rank (Mantel-Cox) p=0.006).